Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MEDP Medpace

Not Yet Opened 06-23 16:00:00 EDT

473.48

+17.82

+3.91%

盘后473.48

+0.000.00%

16:36 EDT

High473.83	Low450.97	Vol312.10K
Open455.66	D1 Closing455.66	Amplitude5.02%
Mkt Cap13.52B	Tradable Cap10.52B	Total Shares28.56M
T/O145.89M	T/O Rate1.40%	Tradable Shares22.22M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MEDP","market":"US","secType":"STK","nameCN":"Medpace","latestPrice":473.48,"timestamp":1782244800000,"preClose":455.66,"halted":0,"volume":312098,"hourTrading":{"tag":"盘后","latestPrice":473.48,"preClose":473.48,"latestTime":"16:36 EDT","volume":5427,"amount":2569620.86,"timestamp":1782246989362,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03910810692182766,"floatShares":22220178,"shares":28558039,"eps":15.90143,"marketStatus":"Not Yet Opened","change":17.82,"latestTime":"06-23 16:00:00 EDT","open":455.66,"high":473.83,"low":450.97,"amount":145888594,"amplitude":0.050169,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":15.90143,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1782288000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1470888000000,"exchange":"NASDAQ","adjPreClose":455.66,"preHourTrading":{"tag":"盘前","latestPrice":454.99,"preClose":455.66,"latestTime":"09:29 EDT","volume":43,"amount":19566.0492,"timestamp":1782221375007,"change":-0.67,"changeRate":-0.00147,"amplitude":0.00147},"postHourTrading":{"tag":"盘后","latestPrice":473.48,"preClose":473.48,"latestTime":"16:36 EDT","volume":5427,"amount":2569620.86,"timestamp":1782246989362,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.982175,"impliedVol":0.4707,"impliedVolPercentile":0.7},"requestUrl":"/m/hq/s/MEDP/tweets","defaultTab":"tweets","newsList":[{"id":"2644760522","title":"Medpace to report second-quarter results after market close, host conference call to discuss results","url":"https://stock-news.laohu8.com/highlight/detail?id=2644760522","media":"Reuters","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644760522?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:23","pubTimestamp":1781641395,"startTime":"0","endTime":"0","summary":"Medpace schedules Q2 2026 results for July 22, 2026, released after the market close.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medpace Holdings Inc. published the original content used to generate this news brief via Business Wire  on June 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL3b10db:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","LU2065170008.USD","LU2065171311.SGD","LU2065169927.USD","BK4588","LU2065171402.SGD","MEDP","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644760514","title":"Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2644760514","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644760514?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:23","pubTimestamp":1781641380,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nTUAVM1LT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","BK4585","BK4588","LU2065171311.SGD","LU2065170008.USD","LU2065169927.USD","MEDP","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643731854","title":"Medpace Holdings (MEDP) Stock Valuation Check After Mixed Recent Share Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=2643731854","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643731854?lang=en_us&edition=fundamental","pubTime":"2026-06-16 14:27","pubTimestamp":1781591257,"startTime":"0","endTime":"0","summary":"Medpace Holdings overview after recent share performance\nMedpace Holdings (MEDP) has drawn fresh attention after a solid move in its share price over the past month, inviting investors to review how its current valuation lines up with recent fundamentals.\nSee our latest analysis for Medpace Holdings.\nThat recent 12.6% 1 month share price return stands out against a weaker year to date share price return, while a 1 year total shareholder return of 56.9% suggests longer term holders have still...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/medpace-holdings-medp-stock-valuation-check-after-mixed-rece","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/medpace-holdings-medp-stock-valuation-check-after-mixed-rece","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065171402.SGD","LU2065169927.USD","BK4121","MEDP","LU2065170008.USD","BK4588","LU2065171311.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643029412","title":"Pritelivir Trial Update Highlights Medpace’s Role in Drug-Resistant HSV Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2643029412","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643029412?lang=en_us&edition=fundamental","pubTime":"2026-06-13 00:30","pubTimestamp":1781281856,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc ($MEDP) announced an update on their ongoing clinical study. Medpace Holdings, Inc. is helping run a Phase 3 trial that tests ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pritelivir-trial-update-highlights-medpaces-role-in-drug-resistant-hsv-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pritelivir-trial-update-highlights-medpaces-role-in-drug-resistant-hsv-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065171311.SGD","MEDP","BK4121","BK4585","BK4588","LU2065170008.USD","LU2065171402.SGD","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641454106","title":"How Investors Are Reacting To Medpace Holdings (MEDP) Executive Shakeup Amid Securities Class Action Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2641454106","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641454106?lang=en_us&edition=fundamental","pubTime":"2026-06-08 12:31","pubTimestamp":1780893114,"startTime":"0","endTime":"0","summary":"In early June 2026, Medpace Holdings, Inc. appointed long-time executive Brad W. Hansman as Executive Vice President, Operations, sharing principal operating officer responsibilities alongside Susan E. Burwig.\nAt the same time, Medpace is confronting a wave of securities class action lawsuits alleging misleading statements about backlog cancellations and book-to-bill projections, raising questions about its disclosure practices and governance.\nWe’ll now examine how the surge in securities...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/how-investors-are-reacting-to-medpace-holdings-medp-executiv","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/how-investors-are-reacting-to-medpace-holdings-medp-executiv","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","ISBC","LU2065169927.USD","LU2065171402.SGD","LU2065170008.USD","BK4121","BK4585","LU2065171311.SGD","BK4211","MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641404167","title":"Medpace Elevates Brad Hansman to Executive Operations Role","url":"https://stock-news.laohu8.com/highlight/detail?id=2641404167","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641404167?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:56","pubTimestamp":1780606577,"startTime":"0","endTime":"0","summary":"Medpace Holdings ( ($MEDP) ) has issued an announcement. Effective June 1, 2026, Medpace Holdings, Inc. appointed long-time executive Brad W. Hansm...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medpace-elevates-brad-hansman-to-executive-operations-role?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medpace-elevates-brad-hansman-to-executive-operations-role?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU2065169927.USD","LU2065171402.SGD","MEDP","LU2065170008.USD","LU2065171311.SGD","BK4585","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641676111","title":"Medpace says Exec VP of Operations Brad W. Hansman files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2641676111","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641676111?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:44","pubTimestamp":1780605885,"startTime":"0","endTime":"0","summary":"Medpace named Exec. VP of Operations Brad W. Hansman as a reporting officer, disclosing 697 shares held plus RSUs for 5,500 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medpace Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL5wNP4H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","BK4588","BK4585","BK4121","LU2065171311.SGD","LU2065170008.USD","MEDP","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641626701","title":"Medpace names Brad Hansman executive vice president of operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2641626701","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641626701?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:12","pubTimestamp":1780603929,"startTime":"0","endTime":"0","summary":"Medpace appointed Brad W. Hansman as executive vice president, operations, effective June 1, 2026.Hansman will share principal operating officer duties with Susan E. Burwig, also an executive vice president, operations.He joined in 2011 in finance and accounting, later moved into operations leadership overseeing study start-up, logistics, regulatory affairs.Before Medpace, Hansman worked at Joseph Decosimo as an audit supervisor, earlier held auditor roles at Macy’s.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medpace Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 0","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL4D34bG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065169927.USD","BK4103","BK4121","BK4585","BK4220","LU2065170008.USD","LU2065171311.SGD","MEDP","LU2065171402.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641169688","title":"BEACON Phase III Rugonersen Trial Puts Medpace in Focus for Rare Disease Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2641169688","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641169688?lang=en_us&edition=fundamental","pubTime":"2026-06-05 00:34","pubTimestamp":1780590855,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc ($MEDP) announced an update on their ongoing clinical study. The BEACON Phase III study, titled “A Randomized, Multi-center, D...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beacon-phase-iii-rugonersen-trial-puts-medpace-in-focus-for-rare-disease-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beacon-phase-iii-rugonersen-trial-puts-medpace-in-focus-for-rare-disease-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4134","BK4121","ISBC","BK4588","LU2065171402.SGD","BK4585","LU2065169927.USD","MEDP","III","LU2065170008.USD","LU2065171311.SGD","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640996017","title":"Top Medpace Insider Executes Major Multi-Million Dollar Stock Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2640996017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640996017?lang=en_us&edition=fundamental","pubTime":"2026-06-02 10:10","pubTimestamp":1780366202,"startTime":"0","endTime":"0","summary":"New insider activity at Medpace Holdings ( ($MEDP) ) has taken place on June 1, 2026. In a notable insider transaction, Medpace Holdings’ General C...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-medpace-insider-executes-major-multi-million-dollar-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-medpace-insider-executes-major-multi-million-dollar-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065171402.SGD","LU2065169927.USD","BK4121","MEDP","LU2065170008.USD","BK4588","LU2065171311.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640736964","title":"Medpace General Counsel Stephen P. Ewald sells 16,349 shares for $7.36 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2640736964","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640736964?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:28","pubTimestamp":1780345728,"startTime":"0","endTime":"0","summary":"Medpace: General Counsel and Corporate Secretary Stephen P. Ewald sold 16,349 shares on May 28 at USD 450.Ewald exercised employee stock options for 16,349 shares the same day at USD 138.87.Directly held common shares fell to 20,343 following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medpace Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL55PtsT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Medpace General Counsel Stephen P. Ewald sells 16,349 shares for $7.36 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","BK4121","LU2065169927.USD","BK4585","MEDP","LU2065171402.SGD","LU2065170008.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638075307","title":"Assessing Medpace Holdings (MEDP) Valuation After Securities Class Actions And Fourth Quarter 2025 Fallout","url":"https://stock-news.laohu8.com/highlight/detail?id=2638075307","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638075307?lang=en_us&edition=fundamental","pubTime":"2026-05-25 04:21","pubTimestamp":1779654115,"startTime":"0","endTime":"0","summary":"Why a wave of lawsuits has put Medpace Holdings (MEDP) in the spotlight\nRecent securities class actions against Medpace Holdings (MEDP) allege false and misleading statements about book to bill guidance, backlog cancellations, and business prospects, with investors pointing to fourth quarter 2025 results as the turning point.\nSee our latest analysis for Medpace Holdings.\nMedpace’s share price has recently been volatile, with a 7 day share price return of 4.22% and a 30 day share price return...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/assessing-medpace-holdings-medp-valuation-after-securities-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/assessing-medpace-holdings-medp-valuation-after-securities-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065169927.USD","BK4588","LU2065171311.SGD","LU2065170008.USD","BK4585","BK4121","MEDP","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636693538","title":"Medpace shareholders approve governance changes enhancing voting rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2636693538","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636693538?lang=en_us&edition=fundamental","pubTime":"2026-05-20 02:57","pubTimestamp":1779217054,"startTime":"0","endTime":"0","summary":"The latest update is out from Medpace Holdings ( ($MEDP) ). At its May 15, 2026 annual meeting, Medpace Holdings, Inc. shareholders approved amendm...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medpace-shareholders-approve-governance-changes-enhancing-voting-rights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medpace-shareholders-approve-governance-changes-enhancing-voting-rights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065171402.SGD","LU2065169927.USD","BK4121","MEDP","LU2065170008.USD","BK4588","LU2065171311.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636866276","title":"Medpace Holdings shareholders approve charter amendments removing supermajority voting requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2636866276","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636866276?lang=en_us&edition=fundamental","pubTime":"2026-05-20 02:47","pubTimestamp":1779216456,"startTime":"0","endTime":"0","summary":"Medpace held its annual shareholder meeting on May 15, 2026.Shareholders backed amendments to the company’s charter to eliminate supermajority voting requirements, with the changes taking effect on May 18, 2026 upon filing.They also supported a separate charter amendment removing limits on shareholders calling special meetings, which became effective on May 18, 2026 upon filing.The board subsequently amended the bylaws to allow shareholders owning at least 25% of voting power to call a special meeting, subject to notice requirements and a one-year continuous ownership condition.A non-binding shareholder proposal seeking the ability to call a special meeting did not pass.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medpace Holdings I","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL6BzLm8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","BK4121","MEDP","LU2065169927.USD","BK4585","LU2065170008.USD","BK4588","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631582783","title":"Is It Time To Reassess Medpace Holdings (MEDP) After The Recent 20% Share Price Slide?","url":"https://stock-news.laohu8.com/highlight/detail?id=2631582783","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631582783?lang=en_us&edition=fundamental","pubTime":"2026-04-29 00:16","pubTimestamp":1777392968,"startTime":"0","endTime":"0","summary":"If you are wondering whether Medpace Holdings at around US$421 per share is still offering value after a strong multi year run, the key is to look past the headline price and into what buyers are actually paying for the business.\nThe stock has recently seen a 20.3% decline over 7 days and a 6.6% decline over 30 days, although the 1 year return sits at 41.3% and the 3 year return at 104.1%.\nRecent coverage has focused on Medpace as a contract research organization supporting clinical...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/is-it-time-to-reassess-medpace-holdings-medp-after-the-recen-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/is-it-time-to-reassess-medpace-holdings-medp-after-the-recen-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065171402.SGD","DCF","LU2065171311.SGD","MEDP","BK4585","BK4121","LU2065170008.USD","LU2065169927.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630633399","title":"Tractor Supply, Lululemon, and Northrop Grumman Are Among Top 10 Large-Cap Losers Last Week (April 20-April 24): Are The Others In Your Portfolio?","url":"https://stock-news.laohu8.com/highlight/detail?id=2630633399","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630633399?lang=en_us&edition=fundamental","pubTime":"2026-04-27 00:32","pubTimestamp":1777221120,"startTime":"0","endTime":"0","summary":"Large-cap stocks slid sharply last week, pressured by earnings misses, weak guidance and analyst downgrades across sectors.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/26/Lululemon-Sign-At-The-Entrance-Of-Retail.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/26/Lululemon-Sign-At-The-Entrance-Of-Retail.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/large-cap/26/04/52052918/tractor-supply-lululemon-and-northrop-grumman-are-among-top-10-large-cap-losers-last-week-april-20-april-24-are-the-others-in-your-portfolio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/large-cap/26/04/52052918/tractor-supply-lululemon-and-northrop-grumman-are-among-top-10-large-cap-losers-last-week-april-20-april-24-are-the-others-in-your-portfolio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["IE00BLSP4452.SGD","LU0130103400.USD","LU2023250504.SGD","LU0320765489.SGD","BK4187","LU0312595415.SGD","LU0124676726.USD","BK4202","BK4604","BK4097","LU1868837136.USD","LULG","CHTR","LU2275660780.HKD","BK4603","LU0061475181.USD","BK4121","LU1280957306.USD","LMTL","LU2238339852.HKD","LU1868836591.USD","LU1941712348.USD","LU2065170008.USD","IE00BZ199S13.USD","TSCO","LU0477156797.USD","BK4516","LU0096364046.USD","LU2023250843.SGD","LU2106854487.HKD","LU1929549753.HKD","BK4588","BK4559","LU0477156953.USD","LU0823411888.USD","LU0098860793.USD","BK4580","LU0130518102.USD","LU1496350502.SGD","BK4104","LU1941712264.USD","LU0320765646.SGD","LU1169589451.USD","LU1064131342.USD","LU2413666699.HKD","IE00B19Z9Z06.USD","LU0070302665.USD","LU1868836757.USD","LU2264538146.SGD","LU1169590202.USD","LU1244550577.SGD","LU1201861165.SGD","IE00B894F039.SGD","LU2413666426.HKD","LU0689626769.HKD","IE00BLSP4239.USD","LU0211331839.USD","BK4534","LU0130102774.USD","LU1868836914.USD","BK4145","LU1868837300.USD","LU1162221912.USD","MEDP","LU2298064838.USD","IE00BN8TJ469.HKD","LU2360107325.USD","QXO","LU2211817866.USD","LU0980610538.SGD","BK4564","LU1917777945.USD","LU1939255532.USD","LMT","LU1244550221.USD","LU0390134368.USD","LU0289960550.SGD","IE0004086264.USD","LU1988902786.USD","LU0648000940.SGD","IE0004091025.USD","LU1983260115.SGD","LU0130517989.USD","LMTS","LU1861214812.USD","LU1585245621.USD","LU0648001328.SGD","LU0208291251.USD","LU1861219969.SGD","BK4504","GB00BDT5M118.USD","IE0034235188.USD","LU2065169927.USD","LU1244550494.USD","IE00BZ9MQY76.HKD","LU0175139822.USD","BK4200","BK4585","TEL","LU1974910355.USD","NOC","LU0302445910.USD","LU2065171311.SGD","LU0640476718.USD","LU1721428933.USD","BK4532","LU1201861249.SGD","LU1430594728.SGD","LU0347712357.USD","LULU","LU2065171402.SGD","IE00B19Z9P08.USD","IE00BBT3K403.USD","IE00BD6J9T35.USD","BK4100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630237387","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Medpace Holdings (MEDP), Siegfried Holding AG (OtherSGFEF) and Edwards Lifesciences (EW)","url":"https://stock-news.laohu8.com/highlight/detail?id=2630237387","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630237387?lang=en_us&edition=fundamental","pubTime":"2026-04-26 20:21","pubTimestamp":1777206082,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Medpace Holdings (MEDP), Siegfried Holding AG (SGF...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-medpace-holdings-medp-siegfried-holding-ag-othersgfef-and-edwards-lifesciences-ew-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-medpace-holdings-medp-siegfried-holding-ag-othersgfef-and-edwards-lifesciences-ew-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EW","LU2065171402.SGD","SG9999001176.USD","BK4581","BK4121","SG9999001176.SGD","LU0345774391.USD","BK4588","XBI","XLV","MEDP","IE00BFXG0V08.USD","LU0029874061.USD","BK4082","SGXZ57979304.SGD","SG9999013999.USD","LU0345774631.USD","LU2065170008.USD","LU0128526141.USD","LU2065171311.SGD","BK4504","IE00BN0W2V16.EUR","BK4210","IE00BN0W2W23.USD","AG","HCSG","LU2065169927.USD","BK4567","IE00BN0W2T93.GBP","IE00BYQQ9H92.USD","BK4137","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137506792","title":"Stock Track | Medpace Soars 5.05% Intraday Amid Mixed Analyst Actions","url":"https://stock-news.laohu8.com/highlight/detail?id=1137506792","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137506792?lang=en_us&edition=fundamental","pubTime":"2026-04-25 01:33","pubTimestamp":1777051996,"startTime":"0","endTime":"0","summary":"Medpace Holdings (MEDP) experienced a significant price surge of 5.05% during intraday trading on Friday, reflecting strong investor interest.The movement comes as analysts released a flurry of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629415558","title":"Medpace price target lowered to $400 from $460 at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2629415558","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629415558?lang=en_us&edition=fundamental","pubTime":"2026-04-24 20:40","pubTimestamp":1777034441,"startTime":"0","endTime":"0","summary":"BMO Capital lowered the firm’s price target on Medpace (MEDP) to $400 from $460 and keeps a Market Perform rating on the shares. The company’s resu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medpace-price-target-lowered-to-400-from-460-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medpace-price-target-lowered-to-400-from-460-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMO","MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629848080","title":"Medpace Holdings Inc : Bmo Cuts Target Price to $400 From $460","url":"https://stock-news.laohu8.com/highlight/detail?id=2629848080","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629848080?lang=en_us&edition=fundamental","pubTime":"2026-04-24 19:03","pubTimestamp":1777028602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nFWN4170SF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171402.SGD","LU2065171311.SGD","MEDP","BK4585","BK4121","LU2065170008.USD","LU2065169927.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.medpace.com","stockEarnings":[{"period":"1week","weight":0.0257},{"period":"1month","weight":0.094},{"period":"3month","weight":0.0143},{"period":"6month","weight":-0.172},{"period":"1year","weight":0.5341},{"period":"ytd","weight":-0.157}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0162},{"period":"3month","weight":0.1169},{"period":"6month","weight":0.0626},{"period":"1year","weight":0.2223},{"period":"ytd","weight":0.0758}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.006402},{"month":2,"riseRate":0.3,"avgChangeRate":-0.035449},{"month":3,"riseRate":0.7,"avgChangeRate":0.006916},{"month":4,"riseRate":0.6,"avgChangeRate":-0.007726},{"month":5,"riseRate":0.5,"avgChangeRate":0.025051},{"month":6,"riseRate":1,"avgChangeRate":0.072831},{"month":7,"riseRate":0.666667,"avgChangeRate":0.148095},{"month":8,"riseRate":0.666667,"avgChangeRate":0.032832},{"month":9,"riseRate":0.6,"avgChangeRate":-0.004448},{"month":10,"riseRate":0.5,"avgChangeRate":0.057543},{"month":11,"riseRate":0.7,"avgChangeRate":0.057867},{"month":12,"riseRate":0.7,"avgChangeRate":0.025222}],"exchange":"NASDAQ","name":"Medpace","nameEN":"Medpace"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Medpace(MEDP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Medpace,MEDP,Medpace股票,Medpace股票老虎,Medpace股票老虎国际,Medpace行情,Medpace股票行情,Medpace股价,Medpace股市,Medpace股票价格,Medpace股票交易,Medpace股票购买,Medpace股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Medpace(MEDP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}